Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.93
-0.0900-2.98%
Volume:217.57K
Turnover:644.05K
Market Cap:250.59M
PE:-1.47
High:3.04
Open:3.04
Low:2.90
Close:3.02
Loading ...

Atea Pharma Reviewing Strategic Opportunities After Cutting 25% of Jobs

Dow Jones
·
27 Mar

Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value

GlobeNewswire
·
27 Mar

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires Live
·
27 Mar

Atea Shareholder Seeks Board Change, Plans to Nominate Directors at 2025 Annual Meeting

MT Newswires Live
·
26 Mar

BRIEF-The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

Reuters
·
26 Mar

the Radoff-Jec Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

THOMSON REUTERS
·
26 Mar

Atea Pharmaceuticals issues statement regarding director nominations

TIPRANKS
·
22 Mar

BRIEF-Atea Pharmaceuticals receives notice of director nominations from Bradley Radoff

Reuters
·
22 Mar

Atea Pharmaceuticals: Bradley L. Radoff to Nominate Three Director Candidates to Stand for Election to Co's Board

THOMSON REUTERS
·
22 Mar

Atea Pharmaceuticals Inc - Receives Notice of Director Nominations From Bradley L. Radoff

THOMSON REUTERS
·
22 Mar

Press Release: Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Dow Jones
·
22 Mar

Atea Pharmaceuticals announces presentation of bemnifosbuvir preclinical data

TIPRANKS
·
19 Mar

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
14 Mar

Atea Pharmaceuticals Faces Challenges Amid Workforce Reductions and Cost-Cutting Efforts

TIPRANKS
·
08 Mar

Atea Pharmaceuticals’ Promising Earnings Call Highlights

TIPRANKS
·
08 Mar

Q4 2024 Atea Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Mar